查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1317922

製剂开发外包市场：按服务、剂型和用途- 2023 年至 2030 年全球预测

Formulation Development Outsourcing Market by Service, Dosage Form, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球药品开发外包市场预计到2023年将大幅成长400.1亿美元，年复合成长率为9.78%，预计到2030年将达到惊人的772.6亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球製剂开发外包市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.全球药品开发外包市场规模及预测为何？

2.在预测期内，COVID-19对全球药物开发外包市场的阻碍因素与影响为何？

3. 在预测期内，全球药物开发外包市场需要投资哪些产品/细分市场/用途/领域？

4.全球药品开发外包市场的竞争策略为何？

5. 全球药品开发外包市场的技术趋势和法律规范是什么？

6.全球药品开发外包市场主要厂商的市占率为何？

7. 哪些型态和策略措施被认为适合进入全球药品开发外包市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 由于慢性病和感染疾病的沉重负担，新药需求不断增加
      • 专注于开发提高生物利用度的水溶性差的化合物
      • 全球临床研究数量正在迅速增加
    • 抑制因素
      • 外包药物研发的成本很高。
    • 机会
      • 增加研发费用以改善製剂开发外包服务
      • 製剂开发新技术的开发
    • 任务
      • 与製剂开发外包相关的品管复杂性
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章製剂开发外包市场：依服务分类

  • 介绍
  • 配方最佳化
    • 第一阶段
    • 第二阶段
    • 第三阶段
    • 第四阶段
  • 製剂前服务
    • 分析服务
    • 发现和临床前服务

第7章剂型开发外包市场

  • 介绍
  • 注射
  • 口服
  • 局部的

第8章製剂开发外包市场：依用途

  • 介绍
  • 心血管
  • 遗传疾病
  • 感染疾病
  • 神经病学
  • 肿瘤学
  • 呼吸系统

第9章美洲医药开发外包市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太製剂开发外包市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲/中东/非洲医药开发外包市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-0D217D5AE52C

The Global Formulation Development Outsourcing Market is forecasted to grow significantly, with a projected USD 40.01 billion in 2023 at a CAGR of 9.78% and expected to reach a staggering USD 77.26 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Formulation Development Outsourcing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Formulation Development Outsourcing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Service, market is studied across Formulation Optimization and Pre-formulation Services. The Formulation Optimization is further studied across Phase I, Phase II, Phase III, and Phase IV. The Pre-formulation Services is further studied across Analytical Services and Discovery & Preclinical Services. The Pre-formulation Services is projected to witness significant market share during forecast period.

Based on Dosage Form, market is studied across Injectable, Oral, and Topical. The Oral is projected to witness significant market share during forecast period.

Based on Application, market is studied across Cardiovascular, Genetic Disorders, Infectious Diseases, Neurology, Oncology, and Respiratory. The Oncology is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Formulation Development Outsourcing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Formulation Development Outsourcing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Formulation Development Outsourcing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Formulation Development Outsourcing Market?

4. What is the competitive strategic window for opportunities in the Global Formulation Development Outsourcing Market?

5. What are the technology trends and regulatory frameworks in the Global Formulation Development Outsourcing Market?

6. What is the market share of the leading vendors in the Global Formulation Development Outsourcing Market?

7. What modes and strategic moves are considered suitable for entering the Global Formulation Development Outsourcing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Formulation Development Outsourcing Market, by Service, 2022 vs 2030
  • 4.3. Formulation Development Outsourcing Market, by Dosage Form, 2022 vs 2030
  • 4.4. Formulation Development Outsourcing Market, by Application, 2022 vs 2030
  • 4.5. Formulation Development Outsourcing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for new drugs owing to the high burden of chronic and infectious diseases
      • 5.1.1.2. Huge focus on developing poorly water-soluble compounds to improve bioavailability
      • 5.1.1.3. Rapidly growing number of clinical studies globally
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of formulation development outsourcing
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing R&D spending to improve the formulation development outsourcing services
      • 5.1.3.2. Development of new technologies for formulation development
    • 5.1.4. Challenges
      • 5.1.4.1. Quality control complexities associated with formulation development outsourcing
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Formulation Development Outsourcing Market, by Service

  • 6.1. Introduction
  • 6.2. Formulation Optimization
    • 6.2.1. Phase I
    • 6.2.2. Phase II
    • 6.2.3. Phase III
    • 6.2.4. Phase IV
  • 6.3. Pre-formulation Services
    • 6.3.1. Analytical Services
    • 6.3.2. Discovery & Preclinical Services

7. Formulation Development Outsourcing Market, by Dosage Form

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral
  • 7.4. Topical

8. Formulation Development Outsourcing Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular
  • 8.3. Genetic Disorders
  • 8.4. Infectious Diseases
  • 8.5. Neurology
  • 8.6. Oncology
  • 8.7. Respiratory

9. Americas Formulation Development Outsourcing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Formulation Development Outsourcing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Formulation Development Outsourcing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. FORMULATION DEVELOPMENT OUTSOURCING MARKET RESEARCH PROCESS
  • FIGURE 2. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2022 VS 2030 (%)
  • FIGURE 5. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2022 VS 2030 (%)
  • FIGURE 6. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. FORMULATION DEVELOPMENT OUTSOURCING MARKET DYNAMICS
  • FIGURE 9. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. FORMULATION DEVELOPMENT OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. FORMULATION DEVELOPMENT OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. FORMULATION DEVELOPMENT OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 5. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 6. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 12. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DISCOVERY & PRECLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 16. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. FORMULATION DEVELOPMENT OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 236. FORMULATION DEVELOPMENT OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 237. FORMULATION DEVELOPMENT OUTSOURCING MARKET LICENSE & PRICING